Viewing Study NCT04104802


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-03-11 @ 1:29 PM
Study NCT ID: NCT04104802
Status: WITHDRAWN
Last Update Posted: 2020-02-25
First Post: 2019-06-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Facial Nerve in MRI 3T in the Preoperative Assessment of Parotid Tumors
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Organization:

Study Overview

Official Title: Study of the Facial Nerve in MRI 3T in the Preoperative Assessment of Parotid Tumors
Status: WITHDRAWN
Status Verified Date: 2020-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: refusal of the ansm
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: FACPAR
Brief Summary: Preoperative evaluation of the precise localization of the intrapartotic facial nerve is essential for the ENT surgeon to assess the risk of nerve damage during parotid tumor excision, and inform the patient of the risk of post-paralyzed facial nerve palsy. procedure
Detailed Description: 1. st visit: Inclusion, parotid MRI 3Tesla high resolution with specific sequences and gadolinium injection performed at the A. de Rothschild Foundation. Evaluation by two radiologists of the exact position of the parotid tumor with respect to the trunk of the facial nerve and its first branches, classified into two categories: contact (≤ 5 mm) or distance (\> 5 mm).
2. nd visit: Surgical intervention of the parotid tumor. The surgeon will specify the same data as those collected by the radiologists after the MRI. The surgeon will not be aware of the data concerning the ratios of parotid tumor to facial nerve collected on MRI sequences for research purposes.

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: